Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Liu

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
Clinics and Practice|July 21, 2021
Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung CancerIvy Riano, Shruti R Patel, Stephen V Liu, et al.
Clinical Lung Cancer|March 28, 2025
Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung CancerLuis Paz-Ares, Brinda Gupta, Javier Baena, et al.
Nature Reviews. Clinical Oncology|May 13, 2015
Refining the treatment of NSCLC according to histological and molecular subtypesAnish Thomas, Stephen V Liu, Deepa S Subramaniam, et al.
Frontiers in Oncology|May 20, 2020
Oral Chemotherapy for Treatment of Lung CancerSushma Jonna, Joshua E Reuss, Chul Kim, et al.
Oncology and Therapy|January 27, 2024
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and AtezolizumabReyes Bernabé, Stephen V Liu, Amparo Sánchez-Gastaldo, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Oncogenic gene fusions in cancer: from biology to therapyStephen V Liu, Misako Nagasaka, Judith Atz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2014
Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesStephen V Liu, Vincent A Miller, Marinus W Lobbezoo, et al.
Current Oncology Reports|October 5, 2022
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic ClassJennifer A Marks, Molly Wilgucki, Stephen V Liu, et al.
JTO Clinical and Research Reports|September 30, 2021
<i>EML4-ALK</i> Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case ReportXinyu von Buttlar, Joshua E Reuss, Stephen V Liu, et al.
Oncology and Therapy|September 26, 2023
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and OncologistsStephen V Liu, Ivy B Elkins, Jill Feldman, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
Clinics and Practice|July 21, 2021
Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung CancerIvy Riano, Shruti R Patel, Stephen V Liu, et al.
Clinical Lung Cancer|March 28, 2025
Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung CancerLuis Paz-Ares, Brinda Gupta, Javier Baena, et al.
Nature Reviews. Clinical Oncology|May 13, 2015
Refining the treatment of NSCLC according to histological and molecular subtypesAnish Thomas, Stephen V Liu, Deepa S Subramaniam, et al.
Frontiers in Oncology|May 20, 2020
Oral Chemotherapy for Treatment of Lung CancerSushma Jonna, Joshua E Reuss, Chul Kim, et al.
Oncology and Therapy|January 27, 2024
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and AtezolizumabReyes Bernabé, Stephen V Liu, Amparo Sánchez-Gastaldo, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Oncogenic gene fusions in cancer: from biology to therapyStephen V Liu, Misako Nagasaka, Judith Atz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2014
Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesStephen V Liu, Vincent A Miller, Marinus W Lobbezoo, et al.
Current Oncology Reports|October 5, 2022
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic ClassJennifer A Marks, Molly Wilgucki, Stephen V Liu, et al.
JTO Clinical and Research Reports|September 30, 2021
<i>EML4-ALK</i> Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case ReportXinyu von Buttlar, Joshua E Reuss, Stephen V Liu, et al.
Oncology and Therapy|September 26, 2023
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and OncologistsStephen V Liu, Ivy B Elkins, Jill Feldman, et al.
Pageof 19